AUGMENTATION OF WOUND HEALING BY eIF-4E mRNA AND EGF mRNA
Abstract
There is provided a method of augmenting transient protein synthesis in a cell by delivering to the cell mRNA functionally related to protein production. Also provided is a method of augmenting transient protein synthesis in cells by increasing protein synthesis of growth factors from endogenous cellular mRNA and exogenous mRNA delivered to the cells. A treatment for transiently increasing protein production in cells, said treatment comprising mRNA functionally related to protein production is also provided. There is provided a method of augmenting wound healing by delivering mRNA functionally related to wound healing. Further provided is a therapeutic for transiently increasing protein synthesis in cells, said therapeutic comprising mRNA related to protein production.
Claims
exact text as granted — not AI-modified1 . A method for augmenting transient protein synthesis in a cell in vitro by administering mRNA encoding eIF4e directly to the cell, wherein administering said mRNA to said cell transiently increases protein synthesis in said cells.
2 . A non-therapeutic method for augmenting transient protein synthesis in a cell in vivo by administering mRNA encoding eIF4e directly to the cell, wherein administering said mRNA to said cell transiently increases protein synthesis in said cells.Join the waitlist — get patent alerts
Track US2007149475A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.